Marketwatch Granules India gets USFDA nod for sleep aid drug Admin September 25, 2020 The US Food and Drug Administration (USFDA) has approved the abbreviated new drug application (ANDA) for Naproxen Sodium and Diphenhydramine Hydrochloride tablets, 220 mg/25 mg (OTC), Granules said in a BSE filing. – Stocks-Markets-Economic Times Share on Facebook Tweet it Pin it Share it Email
